IP Library Granted Patent US 8,137,289
Granted Patent B2
US 8,137,289 · App. 12/717,566 · Granted Mar 20, 2012

Method and apparatus for obtaining aliquot from liquid-based cytological sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,289
App. No.
12/717,566
Granted
Mar 20, 2012
Kind
B2
Abstract

Sample vials and methods of processing the sample vials are provided. The sample vial comprises a vial container, a sample collection chamber within the vial container, a vial cap configured to be mated with the vial container to enclose the collection chamber, an aliquot chamber, which may be carried by the vial cap or the vial container, and a valve mechanism for selectively sealing and unsealing the aliquot chamber from the collection chamber. The method may comprise flowing an aliquot of the sample from the collection chamber while the sample within the collection chamber is isolated from an environment exterior to the vial, sealing the aliquot chamber from the collection chamber to isolate the aliquot sample from the remaining sample portion, and transferring at least some of the remaining sample portion from the collection chamber to a microscope slide while the aliquot chamber is sealed from the collection chamber. The method further comprises reserving the slide for cytological screening of the sample, and reserving the aliquot sample for deoxynucleic acid (DNA) testing.

Claims (16)

1. A biological specimen sample vial, comprising:

a vial container comprising a sample collection chamber for holding a fluid-based biological specimen sample;

a vial cap configured to be mated with the vial container to enclose the collection chamber;

an aliquot chamber; and

a valve mechanism that comprises an actuator disposed on an external surface of the sample vial, and comprises or is coupled to a wall of the aliquot chamber, the valve mechanism biased to seal the aliquot chamber from the collection chamber unless actively actuated, wherein actuating the valve mechanism unseals the aliquot chamber from the collection chamber allowing an aliquot of the sample to flow from the collection chamber into the aliquot chamber while the collection chamber is isolated from an environment exterior to the vial, and wherein terminating active actuation of the valve mechanism causes the valve mechanism to automatically seal the aliquot chamber from the collection chamber to isolate the aliquot sample from a remaining portion of the sample in the collection chamber,

the sample vial configured such that specimen sample fluid may be removed from the sample collection chamber while the aliquot chamber is sealed from the collection chamber.

2. The sample vial of claim 1 , wherein the vial cap comprises the aliquot chamber and valve mechanism.

3. The sample vial of claim 1 , wherein the vial container comprises the aliquot chamber and valve mechanism.

4. The sample vial of claim 1 , wherein the aliquot chamber abuts the collection chamber.

5. The sample vial of claim 1 , wherein the valve mechanism includes a valve configured to be selectively located within the aliquot chamber to prevent fluid communication between the aliquot chamber and the collection chamber, and displaced from the aliquot chamber to allow fluid communication between the aliquot chamber and the collection chamber.

6. The sample vial of claim 5 , wherein the valve mechanism includes a valve configured to be selectively located at an interface between the aliquot chamber and the collection chamber to prevent fluid communication between the aliquot chamber and the collection chamber, and displaced from the interface to allow fluid communication between the aliquot chamber and the collection chamber.

7. The sample vial of claim 1 , wherein the actuator is configured to be rotationally translated to operably move the valve relative to the aliquot chamber.

8. The sample vial of claim 1 , wherein the actuator is configured to be axially translated to operably move the valve relative to the aliquot chamber.

9. The sample vial of claim 8 , further comprising a spring coupled to the actuator to urge the valve to seal the aliquot chamber from the collection chamber.

10. The sample vial of claim 8 , further comprising a sealed port configured to selectively provide direct access to the aliquot chamber.

11. The sample vial of claim 1 , further comprising a fluid-based, cervical-vaginal sample contained within the collection chamber.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
TWENTY-SECOND SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Apr 15, 2010
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 024239/0432 →